Hashem Younes

Wellness.com Featured Provider
Hashem Younes
AHN Cancer Institute-Med Onc & Infusions at H+W Pavilion Wexford Office

(878) 332-4044

Fax (878) 332-4477 12311 Perry Highway, Suite A Wexford, PA 15090

Call today!

About

Hashem Younes

Hashem Younes practices as a Hematologist in Wexford, PA.He graduated from American University of Beirut Faculty of Medicine.
Primary Specialty

Hematologist

Practice AHN Cancer Institute-Med Onc & Infusions at H+W Pavilion Wexford
Gender Male
Education American University of Beirut Faculty of Medicine
Training UPMCUniversity of Pittsburgh Medical Center, UPMCUniversity of Pittsburgh Medical Center, UPMCUniversity of Pittsburgh Medical Center
Certification American Board of Internal Medicine-Medical Oncology, American Board of Internal Medicine-Hematology
Accepting New Patients
Degrees Medical Doctor
Admitting Hospitals Allegheny General Hospital, West Penn Hospital, Wexford Hospital, Forbes Hospital
Office Name AHN Cancer Institute-Med Onc & Infusions at H+W Pavilion Wexford
Languages English
Business Hours
Monday:9:00 AM - 4:00 PM
Tuesday:9:00 AM - 4:00 PM
Wednesday:9:00 AM - 4:00 PM
Thursday:9:00 AM - 4:00 PM
Friday:9:00 AM - 4:00 PM
Saturday:Closed
Sunday:Closed
Services lymphedema physical therapy, chemotherapy iv infusion, rectal neuroendocrine tumor, neuroendocrine carcinoma, metastatic neuroendocrine tumors, relapsed myeloma, colon adenocarcinoma, neutrophilia, elevated transferrin saturation, elevated ferritin, upper extremity lymphedema, large cell neuroendocrine tumors, metastatic blood cancers, neuroendocrine tumor of the lung, generalized lymphatic anomaly, adenocarcinoma of the bladder, hormone receptor negative breast cancer, nut carcinoma, fibrolamellar carcinoma, ductal carcinoma in situ (dcis), personal history of cancer, secondary cancer screening, long term side effects of cancer treatment, personal history of radiation therapy, personal history of chemotherapy, blood cancer chemotherapy, autoimmune neutropenia (ain), evans syndrome, hemophilia inhibitors, factor thirteen deficiency, factor seven deficiency, hereditary elliptocytosis (he), acquired elliptocytosis, prostate cancer chemotherapy, bladder cancer chemotherapy, testicular cancer chemotherapy, relapsed acute myelogenous leukemia (aml), adolescent and young adult cancer (aya), breast cancer biological targeted therapy, relapsed non hodgkin lymphoma, relapsed hodgkin lymphoma, relapsed acute lymphoblastic leukemia (all), neutrophil disorders, blastic plasmacytoid dendritic cell neoplasm, disseminated intravascular coagulation, hormone receptor positive breast cancer, her2 positive breast cancer, carcinoma of unknown primary, lymphomatoid granulomatosis, intrathecal chemotherapy, maintenance chemotherapy, consolidation chemotherapy, induction chemotherapy, er negative breast cancer, pituitary cancer, chronic myelomonocytic leukemia, malignant adnexal tumor, peripheral t cell lymphoma, intraarterial chemotherapy of tumors, inflammatory breast cancer, recurrent breast cancer, brain metastases, coagulation disorders, bone marrow failure syndromes, waldenstrom macroglobulinemia, liver metastases, adrenal nodules, metastatic breast cancer, hodgkin lymphoma, triple negative breast cancer, cancer genetics, hemoglobinopathies, breast cancer therapy, thrombocytosis, castleman's disease, acute blood loss anemia, blood disorders, lymphopenia, prostate cancer, early detection of cancer, von willebrand disease, adenocarcinoma of lung, acute myelogenous leukemia (aml), acute lymphoblastic leukemia (all), abdominal chemotherapy, breast cancer, multiple endocrine neoplasia type 2b, multiple endocrine neoplasia type 2a, multiple endocrine neoplasia type 2, multiple endocrine neoplasia type 1, papillary cancer of thyroid, medullary cancer of thyroid, follicular cancer of thyroid, poems syndrome, recurrent cervical cancer, squamous cancer of the lung, esophageal cancer, kasabach merritt phenomenon (kmp), anemia of chronic disease Additional Services Oncologist
Consumer Feedback
Add a Review
There are no recent reviews. Be the first!